The company is committed to elevating standards of care by delivering minimally invasive solutions to help detect, diagnose, treat and prevent diseases.
“We transformed our business and grew our market share in Australia from one of the lowest globally to one of the highest over the last twenty years,” shared James Bowe, managing director of Olympus Australia. “Our success is driven by our customer relationships and the fact that we connected every action we took as a business to a patient that needed our equipment for treatment,” he added.
According to Bowe, long-term strategic investments in service, education and training enabled the company to build the Olympus brand and become a market leader. Establishing communities for Australian medical experts was fundamental to the company’s goals and the young doctors with whom the company works with today are tomorrow’s professors and heads of health units.
Olympus’ state-of-the-art diagnostic and therapeutic technologies include endoscopes and surgical energy devices. Products developed and manufactured by Olympus are renowned for their high-quality and precision capabilities.
“We go out of our way to help both patients and healthcare professionals enjoy a better life by personalising our services, offering a seamless experience and delivering good results,” explained Bowe.
The EVIS X1 is Olympus’ most advanced endoscopy platform designed to improve outcomes from disorders relating to the stomach, colon, oesophagus and bronchial diseases. Further enhancing the system’s capabilities is Olympus’ cutting-edge artificial intelligence powered platform ‘ENDO-AID’.
Olympus adapted a virtual-first strategy with on-the-ground support to provide its customers information, education and training through the Olympus Continuum platform.
“Our ‘True to Life’ motto brings the needs of the customer and patient to the forefront”, concluded Bowe. “We will continue to provide unique end-to-end services that give people the opportunity to live more fulfilling lives.”